Reuters logo
BRIEF-Concert Pharma Says PTAB denies Incyte petition challenging CTP-543 patent
October 19, 2017 / 5:04 PM / a month ago

BRIEF-Concert Pharma Says PTAB denies Incyte petition challenging CTP-543 patent

Oct 19 (Reuters) - Concert Pharmaceuticals Inc:

* Concert Pharma says patent trials and appeal board of u.s. patent and trademark office has denied Incyte’s petition to institute IPR​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below